Aquaporin 5 polymorphisms and rate of lung function decline in chronic obstructive pulmonary disease

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Hansel, Nadia N ^a,b   Sidhaye, Venkataramana ^a   Rafaels, Nicholas M ^a   Gao, Li ^a   Gao, Peisong ^a   Williams, Renaldo ^a   Connett, John E ^c   Beaty, Terri H ^b   Mathias, Rasika A ^a   Wise, Robert A ^a   King, Landon S ^a   Barnes, Kahleen C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 5; CIGARETTE SMOKE;

ADULT; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHEAR STRESS; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; SMOKING HABIT; WILD TYPE; CELL LINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; INTERVENTION STUDY; LUNG; LUNG FUNCTION TEST; METABOLISM; MULTICENTER STUDY; PHYSIOLOGY; PLASMID; RANDOMIZED CONTROLLED TRIAL; SMOKING; STATISTICAL MODEL;

AQUAPORIN 5; CELL LINE; GENE FREQUENCY; GENETIC VARIATION; HAPLOTYPES; HUMANS; INTERVENTION STUDIES; LUNG; MODELS, STATISTICAL; PLASMIDS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SMOKING;

EID: 78649924850     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014226     Document Type: Article

References (38)

1. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC (2002) Chronic obstructive pulmonary disease surveillance-nited States, 1971-2000. Respir Care 47(10): 1184-1199.
2. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349(9064): 1498-1504.
3. Bascom R (1991) Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenetics 1(2): 102-106.
4. Hogg JC (2004) Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 364(9435): 709-721.
5. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350(26): 2645-2653.
6. Verkman AS, Matthay MA, Song Y (2000) Aquaporin water channels and lung physiology. Am J Physiol Lung Cell Mol Physiol 278(5): L867-L879.
7. Wang K, Feng YL, Wen FQ, Chen XR, Ou XM, et al. (2007) Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease. Acta Pharmacol Sin 28(8): 1166-1174.
8. Lee MD, Bhakta KY, Raina S, Yonescu R, Griffin CA, et al. (1996) The human Aquaporin-5 gene. Molecular characterization and chromosomal localization. J Biol Chem 271(15): 8599-8604.
9. Ning Y, Ying B, Han S, Wang B, Wang X, et al. (2008) Polymorphisms of aquaporin5 gene in chronic obstructive pulmonary disease in a Chinese population. Swiss Med Wkly 138(39-40): 573-578.
10. Anthonisen NR (1989) Lung Health Study. Am Rev Respir Dis 140(4): 871-872.
11. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, et al. (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 272(19): 1497-1505.
12. Connett JE, Kusek JW, Bailey WC, O'Hara P, Wu M (1993) Design of the Lung Health Study: a randomized clinical trial of early intervention for chronic obstructive pulmonary disease. Control Clin Trials 14(2 Suppl). pp 3S- 19S.
13. Kanner RE, Connett JE, Williams DE, Buist AS (1999) Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 106(4): 410-416.
14. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, et al. (1996) Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med 153(6 Pt 1): 1802-1811.
15. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2): 263-265.
16. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, et al. (2002) The structure of haplotype blocks in the human genome. Science 296(5576): 2225-2229.
17. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3): 559-575.
18. Sidhaye V, Hoffert JD, King LS (2005) cAMP has distinct acute and chronic effects on aquaporin-5 in lung epithelial cells. J Biol Chem 280(5): 3590-3596.
19. Sidhaye VK, Schweitzer KS, Caterina MJ, Shimoda L, King LS (2008) Shear stress regulates aquaporin-5 and airway epithelial barrier function. Proc Natl Acad Sci U S A 105(9): 3345-3350.
20. Glader P, Moller S, Lilja J, Wieslander E, Lofdahl CG, et al. (2006) Cigarette smoke extract modulates respiratory defence mechanisms through effects on Tcells and airway epithelial cells. Respir Med 100(5): 818-827.
21. Serikov VB, Leutenegger C, Krutilina R, Kropotov A, Pleskach N, et al. (2006) Cigarette smoke extract inhibits expression of peroxiredoxin V and increases airway epithelial permeability. Inhal Toxicol 18(1): 79-92.
22. Steinfeld S, Cogan E, King LS, Agre P, Kiss R, et al. (2001) Abnormal distribution of aquaporin-5 water channel protein in salivary glands from Sjogren's syndrome patients. Lab Invest 81(2): 143-148.
23. Hansel NN, Gao L, Rafaels NM, Mathias RA, Neptune ER, et al. (2009) Leptin receptor polymorphisms and lung function decline in COPD. Eur Respir J 34(1): 103-110.
24. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6): 532-555.
25. Sandford AJ, Silverman EK (2002) Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Thorax 57(8): 736-741.
26. He JQ, Connett JE, Anthonisen NR, Pare PD, Sandford AJ (2004) Glutathione S-transferase variants and their interaction with smoking on lung function. Am J Respir Crit Care Med 170(4): 388-394.
27. He JQ, Burkett K, Connett JE, Anthonisen NR, Pare PD, et al. (2006) Interferon gamma polymorphisms and their interaction with smoking are associated with lung function. Hum Genet 119(4): 365-375.
28. Seo T, Pahwa P, McDuffie HH, Nakada N, Goto S, et al. (2008) Interactive effect of paraoxonase-1 Q192R polymorphism and smoking history on the lung function decline in grain workers. Ann Epidemiol 18(4): 330-334.
29. Collaco JM, Vanscoy L, Bremer L, McDougal K, Blackman SM, et al. (2008) Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA 299(4): 417-424.
30. Krane CM, Fortner CN, Hand AR, McGraw DW, Lorenz JN, et al. (2001) Aquaporin 5-deficient mouse lungs are hyperresponsive to cholinergic stimulation. Proc Natl Acad Sci U S A 98(24): 14114-14119.
31. Becker KG (2004) The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 62(2): 309-317.
32. Ogawa E, Ruan J, Connett JE, Anthonisen NR, Pare PD, et al. (2006) Transforming growth factor-beta1 polymorphisms, airway responsiveness and lung function decline in smokers. Respir Med 101(5): 938-943.
33. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, et al. (2000) TGFbeta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 55(6): 459-462.
34. Eden E (2010) Asthma and COPD in Alpha-1 Antitrypsin Deficiency. Evidence for the Dutch Hypothesis. COPD 7(5): 366-374.
35. Tzetis M, Efthymiadou A, Strofalis S, Psychou P, Dimakou A, et al. (2001) CFTR gene mutations-including three novel nucleotide substitutions-and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 108(3): 216-221.
36. Zhang Y, Zhang J, Huang J, Li X, He C, et al. (2010) Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: A meta-analysis. Respirology 15(4): 643-650.
37. Krane CM, Deng B, Mutyam V, McDonald CA, Pazdziorko S, et al. (2009) Altered regulation of aquaporin gene expression in allergen and IL-13-induced mouse models of asthma. Cytokine 46(1): 111-118.
38. Shen Y, Wang Y, Chen Z, Wang D, Wang X, et al. (2010) Role of Aquaporin 5 in antigen-induced airway inflammation and mucous hyperproduction in mice. J Cell Mol Med [Epub ahead of print], Available: http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2010.01103.x/pdf. Accessed November 15, 2010.